Correlation Between Qualigen Therapeutics and Alsea SAB

Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Alsea SAB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Alsea SAB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Qualigen Therapeutics and Alsea SAB de, you can compare the effects of market volatilities on Qualigen Therapeutics and Alsea SAB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Alsea SAB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Alsea SAB.

Diversification Opportunities for Qualigen Therapeutics and Alsea SAB

0.06

Correlation Coefficient

Qualigen Therapeutics  Alsea SAB

Significant diversification

The 3 months correlation between Qualigen and Alsea is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Alsea SAB de in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alsea SAB de and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Alsea SAB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alsea SAB de has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Alsea SAB go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Alsea SAB

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Alsea SAB. In addition to that, Qualigen Therapeutics is 1.2 times more volatile than Alsea SAB de. It trades about -0.01 of its total potential returns per unit of risk. Alsea SAB de is currently generating about 0.02 per unit of volatility. If you would invest  209.00  in Alsea SAB de on December 29, 2024 and sell it today you would earn a total of  3.00  from holding Alsea SAB de or generate 1.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Qualigen Therapeutics  vs.  Alsea SAB de

Qualigen Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Qualigen Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Alsea SAB de

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Alsea SAB de are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Alsea SAB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Qualigen Therapeutics and Alsea SAB

The main advantage of trading using opposite Qualigen Therapeutics and Alsea SAB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Alsea SAB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alsea SAB will offset losses from the drop in Alsea SAB's long position.

The idea behind Qualigen Therapeutics and Alsea SAB de pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.